comparemela.com

Latest Breaking News On - Chief financial officer kathi niffenegger - Page 1 : comparemela.com

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

11.05.2023 - TORONTO, ON / ACCESSWIRE / May 11, 2023 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial results for the three and six months ended March .

United statesUnited kingdomKathi niffeneggerGary koppenjanEdesa biotech incExchange commissionSecurities exchangeStrategic innovation fundBritish columbia securities commissionInternational conventionPar nijhawanChief executive officerChief financial officer kathi niffeneggerThree months ended marchSix months ended marchStrategic innovation

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

United statesKathi niffeneggerNews networkStrategic innovation fundDrug administrationEdesa biotech incInternational conventionEdesa biotechPar nijhawanChief executive officerChief financial officer kathi niffeneggerThree months ended marchSix months ended marchStrategic innovationAcute respiratory distress syndromeAllergic contact dermatitis

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKathi niffeneggerGary koppenjanEdesa biotechviewDrug administrationStrategic innovation fundInternational conventionBritish columbia securities commissionEdesa biotech incSecurities exchangeExchange commissionEdesa biotechPar nijhawanChief executive officerChief financial officer kathi niffenegger

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

TORONTO, ON / ACCESSWIRE / February 10, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial

United statesUnited kingdomEdesa biotechviewKathi niffeneggerGary koppenjanAmerican academy of dermatology annual meetingEdesa biotech incDrug administrationExchange commissionStrategic innovation fundBritish columbia securities commissionSecurities exchangeEdesa biotechFast trackAcute respiratory distress syndromeAllergic contact dermatitis

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKathi niffeneggerGary koppenjanAmerican academy of dermatology annual meetingEdesa biotech incDrug administrationExchange commissionStrategic innovation fundBritish columbia securities commissionSecurities exchangeEdesa biotechFast trackAcute respiratory distress syndromeAllergic contact dermatitisPar nijhawan

vimarsana © 2020. All Rights Reserved.